Skip to Content

Carbidopa and Levodopa Extended-Release Tablets

Last Updated: May 26, 2016
Status: Resolved

Reason for the Shortage
    • Accord could not provide a reason for the shortage.
    • Caraco could not provide a reason for the shortage.
    • Merck could not provide a reason for the shortage.
Available Products
    • Sinemet CR extended release tablet, Merck, 25 mg/100 mg, 100 count, NDC 00006-3919-68
    • Sinemet CR extended release tablet, Merck, 50 mg/200 mg, 100 count, NDC 00006-3918-68
    • Carbidopa and Levodopa extended release tablet, Accord, 25 mg/ 100 mg, 1000 count, NDC 16729-0078-17
    • Carbidopa and Levodopa extended release tablet, Accord, 25 mg/100 mg, 100 count, NDC 16729-0078-01
    • Carbidopa and Levodopa extended release tablet, Accord, 50 mg/200 mg, 100 count, NDC 16729-0079-01
    • Carbidopa and Levodopa extended release tablet, Accord, 50 mg/200 mg, 1000 count, NDC 16729-0079-17
    • Carbidopa and Levodopa extended release tablet, Caraco, 25 mg/100 mg, 100 count, NDC 62756-0461-88
    • Carbidopa and Levodopa extended release tablet, Caraco, 50 mg/200 mg, 100 count, NDC 62756-0457-88
    • Carbidopa and Levodopa extended release tablet, Mylan, 25 mg/100 mg, 100 count, NDC 00378-0088-01
    • Carbidopa and Levodopa extended release tablet, Mylan, 50 mg/200 mg, 100 count, NDC 00378-0094-01
    • Carbidopa and Levodopa extended release tablet, Mylan Institutional, 25 mg/100 mg, 100 count, NDC 51079-0923-20
    • Carbidopa and Levodopa extended release tablet, Mylan Institutional, 50 mg/200 mg, 100 count, NDC 51079-0978-20

Estimated Resupply Dates

    • All presentations are currently available.

Updated

Updated May 26, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Created April 29, 2015 by Jane Chandramouli, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide